By identifying promising discoveries and advancing their translation, CCRM has enabled and supported new companies. As of September 2020, we have co-founded one company, incubated a second and supported the launch of nine more (eleven total) that together have raised over CAN$600 million.

Portfolio Companies

IC-fullmember_0000s_0024_aspect
Endogena Therapeutics
External link to ExCellThera
Feldan Therapeutics
Intelligent Vector Solutions - iVexSol logo
Kisoji Biotechnology
Mesentech
Morophocell Technologies
Notch Therapeutics
panCELLa

Past Exits

 

AVROBIO logo

 

Learn more on our Investing Strategy and Funding and Strategic Support pages.